Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


MJFF-webinar-parkinsons-genetics

Resources & Tools

How Parkinson’s genetics is transforming drug development

Find out about the latest research into Parkinson’s genetics

READ MORE
Tim Peake Walter Reynecke

Global update

Astronaut in space tweets praise to the delight of Parkinson’s painter

Painter is over the moon to receive recognition from astronaut

READ MORE
Duodopa approved in Scotland lead

Advances

Parkinson’s campaigners win fight to have life-changing drug approved

Drug that can “transform” lives is approved for use in Scotland

READ MORE